Brain lesions exhibiting inflammation and neuronal damage are an important part of the pathology of multiple sclerosis. Microarray analysis compares gene expression in two forms of these lesions, and points to new therapies for the disease. (pages 500–508)
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lock, C. et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nature Med. 8, 500–508 (2002).
Wekerle, H., Kojima, K., Lannes-Vieira, J., Lassmann, H. & Linington, C. Animal models. Ann. Neurol. 36 (Suppl.), S47–S53 (1994).
Zavala, F. et al. G-CSF therapy of ongoing experimental allergic encephalomyelitis via chemokine- and cytokine-based immune deviation. J. Immunol. 168, 2011–2019 (2002).
Whitney, L.W. et al. Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays. Ann. Neurol. 46, 425–428 (1999).
Whitney, L.W., Ludwin, S.K., McFarland, H.F. & Biddison, W.E. Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions. J. Neuroimmunol. 121, 40–48 (2001).
Ibrahim, S.M. et al. Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis. Brain 124, 1927–1938 (2001).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tompkins, S., Miller, S. An array of possibilities for multiple sclerosis. Nat Med 8, 451–453 (2002). https://doi.org/10.1038/nm0502-451
Issue Date:
DOI: https://doi.org/10.1038/nm0502-451
This article is cited by
-
Monitoring of multiple sclerosis immunotherapy
Journal of Neurology (2008)